: Kinnate Biopharma started at buy with $32 stock price target at Stifel Nicolaus

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Kinnate Biopharma Inc.

Kinnate Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply